Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

DarwinHealth announces a scientific collaboration with Celgene on a discovery platform in systems biology

Saturday, August 31, 2019

DarwinHealth today announced a multiyear scientific collaboration with Celgene Corporation Celgene to use algorithms based on quantitative systems biology technologies that also underpin the evidence of diagnosis approved by the Reforms on the Improv...

La Jolla Pharmaceutical Company Receives European Commission Approval for GIAPREZA™ (angiotensin II)

Friday, August 30, 2019

La Jolla Pharmaceutical Company a leader in the discovery development and commercialization of innovative therapies intended to significantly improve outcomes in patients suffering from lifethreatening diseases today announced that the European Commi...

European Commission approves Roche’s Tecentriq in combination with Abraxane for people with PD-L1-positive, metastatic triple-negative breast cancer

Thursday, August 29, 2019

Roche today announced that the European Commission has approved Tecentriq atezolizumab plus chemotherapy Abraxane paclitaxel proteinbound particles for injectable suspension albuminbound nabpaclitaxel for the treatment of adult patients with unresect...

Adaptimmune and Noile-Immune Announce Agreement to Develop SPEAR T-Cell Products expressing IL-7 and CCL19 as a next-generation treatment

Thursday, August 29, 2019

Adaptimmune Therapeutics plc a leader in Tcell therapy to treat cancer and NoileImmune Biotech Inc Tokyo Japan a biotechnology company focusing on the development of innovative cancer immunotherapies today announced that they will codevelop nextgener...

Harbour BioMed and PPD Form Strategic Collaboration to Develop Innovative Therapeutics for Oncology and Immunology

Wednesday, August 28, 2019

Harbour BioMed HBM a global clinicalstage biopharmaceutical company and Pharmaceutical Product Development LLC PPD a leading global contract research organization CRO today announced a strategic collaboration to develop HBMs innovative therapeutics i...

Machavert Pharmaceuticals Signs Exclusive License Agreement to Control RAL GTPase Inhibitors against KRAS Cancers

Wednesday, August 28, 2019

Machavert Pharmaceuticals a preclinical stage pharmaceutical company focused on precision medicine cancer therapies announced today that it has obtained a full exclusive license on RAL GTPase RAL inhibitors from the University of Colorado The license...

Zogenix Announces Acquisition of Modis Therapeutics, Inc.

Tuesday, August 27, 2019

Zogenix Inc a global pharmaceutical company developing rare disease therapies today announced that it has entered into a definitive agreement to acquire Modis Therapeutics Inc a privately held biopharmaceutical company focused on developing novel the...

ADC Therapeutics and Freenome Enter Biomarker Development Collaboration

Tuesday, August 27, 2019

ADC Therapeutics an oncology drug discovery and development company that specializes in the development of antibody drug conjugates ADCs and Freenome a biotechnology company that has pioneered the most comprehensive multiomics platform for early canc...

HotSpot Therapeutics Announces Acquisition of Macroceutics, Inc.

Monday, August 26, 2019

HotSpot Therapeutics Inc a biotechnology company pioneering the discovery of natures regulatory sites to advance allosteric drug discovery today announced the acquisition of Macroceutics Inc a provider of DNAencoded library DEL screening technologies

Iconic Therapeutics Signs Ophthalmology Option Agreement

Friday, August 23, 2019

Iconic Therapeutics a private biopharmaceutical company focused on novel therapeutics for serious diseases such as cancer and agerelated macular degeneration today announced that the Company has signed an agreement with Novartis that provides Novart...

Latest Issue
Get instant
access to our latest e-book